The Journal of Inorganic and Organometallic Polymers and Materials, published by SPRINGER, is a premier academic journal dedicated to advancing the field of materials science, particularly in the domains of inorganic and organometallic polymers. Established in 1996, this journal has successfully converged multiple years of research, reflecting the dynamic evolution of the field through to 2024. With an impressive Scopus Rank placing it in the top 81st percentile in both Materials Chemistry and Polymers and Plastics, it is recognized for its significant contributions and innovations. The journal is classified in the prestigious Q2 Category, indicating its influence and relevance among leading publications. While it operates under a subscription model, the journal is committed to disseminating cutting-edge research, providing insights that empower researchers, professionals, and students to push the boundaries of materials chemistry and polymer science. Its focus on high-quality, peer-reviewed articles ensures that readers are equipped with the latest findings and methodologies that drive this exciting and rapidly evolving field.

Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.

Bioinspired Biomimetic and Nanobiomaterials is a distinguished journal published by Emerald Group Publishing Ltd, focusing on the cutting-edge intersection of biomaterials, engineering, and nanotechnology. Since its inception in 2012, the journal has provided a vital platform for researchers, professionals, and students to disseminate innovative findings that draw inspiration from nature to develop novel biomimetic and bioinspired materials. Although currently indexed in the fourth quartile for Biomaterials and third quartile for miscellaneous Engineering in 2023, the journal is committed to improving its standing and impact by welcoming contributions that exploit the functional capabilities of nanoscale and biomimetic structures. With a strategic aim to foster interdisciplinary collaboration, this journal plays an instrumental role in advancing the field of biomaterials and engineering. Join our community and contribute to shaping the future of sustainable material design and applications.

Cancer Nanotechnology is a cutting-edge peer-reviewed journal dedicated to advancing the field of cancer research through innovative nanotechnology applications. Published by SPRINGER WIEN, this open-access journal, established in 2010, provides a vital platform for the dissemination of high-quality research with a focus on the intersection of nanotechnology, oncology, and biomedical engineering. With a commitment to promoting accessibility and fostering collaboration, Cancer Nanotechnology has gained impressive rankings within specialized categories, including Q2 in Biomedical Engineering and Pharmaceutical Science. The journal's rigorous selection process ensures that only the most impactful studies reach its audience, making it a must-read for researchers, professionals, and students eager to explore the latest advancements and methodologies in cancer treatment. With its scope encompassing critical topics that bridge multiple disciplines—including physical chemistry and toxicology—Cancer Nanotechnology positions itself as an influential resource for shaping the future of cancer therapies.

NANO is an esteemed academic journal published by World Scientific Publishing Co. Pte Ltd, focusing on the frontier of nanoscience and nanotechnology. With ISSN 1793-2920 and E-ISSN 1793-7094, this journal has been a pivotal platform for disseminating innovative research from 2008 to 2024. Located in Singapore, NANO has established itself within the academic community, currently holding notable rankings in the Q3 Category for both Condensed Matter Physics and Materials Science, as well as a Q4 Category status in Nanoscience and Nanotechnology. Though it operates under a non-open access model, its contributions are invaluable for researchers, professionals, and students seeking to stay abreast of the latest advancements and interdisciplinary approaches within the nanoscale domain. By providing in-depth articles, reviews, and insights, NANO plays a significant role in advancing our understanding of materials at the nanoscale, thereby fostering innovation and collaboration across related fields.

Materials is an esteemed journal published by MDPI, dedicated to advancing the fields of Condensed Matter Physics and Materials Science. With its commitment to Open Access since its inception in 2008, the journal has made significant strides in disseminating high-quality research globally, allowing researchers, professionals, and students easy access to cutting-edge studies without financial barriers. Hailing from Switzerland, the journal has shown remarkable growth and prominence, currently ranked in the Q2 quartile in its categories according to the latest assessments, which highlights its impact within the community. As the journal converges its focus from 2008 to 2024, it aims to continually foster a robust exchange of knowledge on innovative materials and their applications, thereby supporting the evolving landscape of science and technology. With an E-ISSN of 1996-1944 and a user-friendly platform, Materials is poised to be a leading choice for scholars eager to contribute to and engage with pioneering research.

Nanomedicine Journal, published by Mashhad University of Medical Sciences, serves as a vital platform for research and developments in the dynamic field of nanotechnology applied to medicine. With an ISSN of 2322-3049 and an E-ISSN of 2322-5904, this Open Access journal, operational since 2013, makes cutting-edge research freely accessible to encourage collaborative efforts in this rapidly evolving domain. The journal navigates various areas, including bioengineering, biomedical engineering, materials science, and pharmacology, holding prestigious rankings in categories relevant to these fields. The 2023 Scopus Rankings reveal its significant standing within the scientific community, particularly with a 76th percentile in general medicine. By bridging the gap between laboratory technologies and clinical applications, the Nanomedicine Journal aims to empower researchers, professionals, and students alike to contribute to the innovative landscape of nanomedicine. With a convergence period extending from 2019 to 2024 and an established reputation, this journal is essential for those pursuing advancements in therapeutic solutions and diagnostics through nanotechnology.

JOURNAL OF NANOPARTICLE RESEARCH, published by SPRINGER, is a pivotal platform in the interdisciplinary field of nanotechnology, encompassing atomic and molecular physics, bioengineering, chemistry, condensed matter physics, and materials science. Operating since 1999 and converging through 2024, this journal presents cutting-edge research and innovations in nanoparticle science, aiming to bridge theoretical studies with practical applications. With a diverse scope that attracts articles ranked in various Q2 and Q3 category quartiles across its fields, including Bioengineering and Nanoscience and Nanotechnology, it ranks favorably within Scopus metrics, ensuring high visibility and impact among researchers. While the journal operates under traditional access models, it remains a critical resource for professionals and students alike, empowering them to advance their knowledge and drive future discoveries in this rapidly evolving area of study.

ADVANCED DRUG DELIVERY REVIEWS, published by ELSEVIER, is a leading journal in the field of pharmaceutical sciences, particularly acclaimed for its contributions to the disciplines of pharmacology, toxicology, and pharmaceutics. With an impressive 2023 Scopus rank of #1 out of 183 in its category, this journal is situated in the Q1 quartile, reflecting its high impact and the relevance of its published research. Since its inception in 1987, it has continually focused on the latest advancements in drug delivery systems, making it an indispensable resource for researchers, professionals, and students interested in the innovative developments that shape the pharmaceutical landscape. The journal aims to publish comprehensive and authoritative reviews that foster a deeper understanding of drug delivery mechanisms, technologies, and their clinical applications. Although it operates under a subscription model, the value it provides through rigorous peer-reviewed content ensures it remains an essential tool for anyone seeking to enhance their knowledge in this rapidly evolving field.

Nano LIFE, published by World Scientific Publishing Company, is a multidisciplinary journal that delves into the dynamic fields of bioengineering, biomedical engineering, and pharmaceutical science, providing a platform for researchers to disseminate their cutting-edge findings. With an ISSN of 1793-9844 and e-ISSN 1793-9852, this journal emphasizes the significance of nanoscale research in healthcare and technology, positioning itself as a vital resource for professionals and academics alike. Although currently categorized in the Q4 quartile for multiple scientific disciplines in 2023, its unique focus on the intersection of nanotechnology and life sciences aims to elevate the discourse in these rapidly evolving sectors. Researchers can anticipate publishing innovative methodologies and results, contributing to the overall understanding and application of nanotechnology in medicine. Located in Singapore, Nano LIFE not only serves the global research community but also reflects the growing interest in nanotechnology across diverse fields.